DrugPatentWatch Database Preview
Email this page to a colleagueSee Plans and Pricing
« Back to Dashboard
Clenpiq is a drug marketed by Ferring Pharms Inc and is included in one NDA. There is one patent protecting this drug and one Paragraph IV challenge.
This drug has twelve patent family members in nine countries.
The generic ingredient in CLENPIQ is citric acid; magnesium oxide; sodium picosulfate. There are five drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the citric acid; magnesium oxide; sodium picosulfate profile page.
There is one Paragraph IV patent challenge for this drug. This may lead to patent invalidation or a license for generic production.
There is one tentative approval for the generic drug (citric acid; magnesium oxide; sodium picosulfate), which indicates the potential for near-term generic launch.
Indicators of Generic Entry
Summary for CLENPIQ
|Suppliers / Packagers:||2|
|Bulk Api Vendors:||1|
|Formulation / Manufacturing:||see details|
|Drug Prices:||Drug price information for CLENPIQ|
|Patent Litigation and PTAB cases:||See patent lawsuits and PTAB cases for CLENPIQ|
|DailyMed Link:||CLENPIQ at DailyMed|
Recent Clinical Trials for CLENPIQ
Identify potential brand extensions & 505(b)(2) entrants
|Ferring Pharmaceuticals||Phase 1/Phase 2|
Recent Litigation for CLENPIQ
Identify potential future generic entrants
District Court Litigation
|Ferring Pharmaceuticals Inc. v. Lupin Inc.||2019-05-16|
Pharmacology for CLENPIQ
Synonyms for CLENPIQ
|Citric acid / magnesium oxide / sodium picosulfate|
|Citric acid mixture with magnesium oxide and sodium picosulfate|
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Ferring Pharms Inc||CLENPIQ||citric acid; magnesium oxide; sodium picosulfate||SOLUTION;ORAL||209589-001||Nov 28, 2017||RX||Yes||Yes||Start Trial||Start Trial||Y||Start Trial|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|